The Meristem.R&D Knowledge Garden

← All research beats

research beat

The HKG Longevity Sweep — verified ground truth in a hype-saturated field

HKGMKGTKGBKG
owner / routes to
HKG (analyst) — Claude/Fable on schedule, Chilly on-drop; rated by John Bou → The Specimen Cabinet (HKG shelf) + John Bou's HKG healthcare work
cadence
Rides the twice-weekly metronome (Tue + Fri, 08:00 local); on-drop out of band. Stricter freshness: an HKG verified card >~90 days without re-check is a re-verification candidate.
started
2026-07-18
scope
The longevity specialisation of the Standing Frontier Sweep. Nine veins: cellular rejuvenation / partial reprogramming; NAD+ · senescence · senolytics; biological-age clocks & aging biomarkers; metabolic / GLP-1 & cardiovascular outcomes; structural repair (glycation / AGEs / crosslinks); supplement provenance & quality; clinical-trial navigation for age-related disease; conflict-of-interest transparency; and health × machine-layer (verification-as-moat). Each run sweeps for leads, deep-verifies keepers against a PRIMARY, adds a conflict-of-interest check, cards the survivors honestly (real science and commercial claims weighted as different objects), and logs what changed.
primary sources
Leads (never primary): longevity podcasts, founder/company PR, trade press, supplement marketing · Primaries: PubMed · ClinicalTrials.gov · bioRxiv / medRxiv · FDA (approvals, INDs, GRAS) · peer-reviewed journals · Conflict layer: company/founder financial interest, sponsor of the trial, who sells the product

Longevity is where "make money AND address a meta-crisis" is clearest — aging is the top risk factor for most chronic disease, and a real clinical inflection has arrived (partial reprogramming reached humans with ER-100, NCT07290244). It is also the field most saturated with hype. So HKG's bet is not to pick a molecule; it is to be the verified, conflict-free signal that separates real science from marketing — and to feed that ground truth to John Bou's healthcare work. Verification is the product.

The veins. Nine of them, from the mechanism frontier (reprogramming, senolytics, glycation repair) through measurement (biological-age clocks, aging biomarkers — the HKG × MKG edge) to the commercial reality (supplement provenance, conflict-of-interest transparency) and the machine layer (HKG × TKG: verification-as-moat as medical answers go free).

The loop. Read the lessons → sweep the veins for leads → deep-verify each keeper against a primary (PubMed / ClinicalTrials.gov / bioRxiv-medRxiv / FDA / journal) → add the conflict-of-interest check → card the survivors, weighting lab science and commercial claims separately → log what changed → validate to zero errors → hand the founder the build → route decision-ready cards to John Bou and take his clinical reality back as new leads.

Why stricter here. Longevity claims decay and flip fast — the NMN regulatory status whipsawed (excluded 2022, reversed 2025), and a Sinclair-affiliated "dog supplement reverses aging" cycle in 2024 triggered a field revolt and a resignation. "Verified" always means verified as of a date, and in this field the date matters more than almost anywhere else. Cards that pass their freshness window are re-verification candidates on the next sweep, not permanent truths.

The flagship it feeds. This sweep keeps the HKG-tagged verified corpus fresh enough to run the substrate demo on demand — cheap model grounded in HKG's verified cards vs. a frontier model on the open web, on the questions HKG customers actually ask. Its two anchors — CMLase (can glycation be reversed?) and HealthBench Professional (free superhuman answers → verification is the scarce layer) — were verified and carded on this beat's first pass, 18 Jul 2026.

Findings

— 0 filed

No findings filed yet.

Guardrail

Not medical advice; no supplement-stack endorsement; no dosing served as advice — HKG describes and verifies, it does not prescribe. Conflict-of-interest vigilance is non-negotiable in this field, and lab science and commercial claims are weighted separately (the Sinclair lesson). Internal-first and gated. Primary sources only for "verified"; every card carries a freshness date and a falsifier; a run of only-verified longevity cards is a red flag, not a triumph. Nothing here diverts engineering from the BKG paying-customer P0. Claude stages + validates; the founder commits, builds, and deploys; John Bou rates decision-usefulness. A card is not "live" until built and deployed.